| Title | Description | ||||
|---|---|---|---|---|---|
| Active Ingredients |
|
||||
| Dosage Form | CAPSULE, EXTENDED RELEASE | ||||
| Packaging | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-103-01), 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-103-07), 5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-103-10), 7 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-103-12), 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-103-30), | ||||
| Pharm Type | Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE] |